Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer

Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer

Current standard-of-care for patients with pancreatic ductal adenocarcinoma (PDAC) focusses on chemotherapeutic regimens and pancreatic cancer surgery. However, limited treatment options, late diagnosis in advanced tumor stages and the aggressive behavior of PDAC contribute to the high mortality of...

Full description

Bibliographic Details
Main Authors: Ivonne Regel, Julia Mayerle, Ujjwal Mukund Mahajan
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
pancreatic ductal adenocarcinoma
cancer subtypes
targeted therapy
biomarker
epigenetic
metabolome
Online Access:https://www.mdpi.com/2072-6694/12/4/1024

Similar Items

Similar Items